SE: AstraZeneca Says Too Early to Speculate on Vaccine Regulation

Bloomberg Markets & Finance via Youtube


Nov.23 — AstraZeneca Executive Vice President Biopharmaceuticals Business Unit President Ruud Dobber discusses the company’s coronavirus vaccine and questions being raised by analysts about its efficacy. He speaks on “Bloomberg Markets.”